Click for best price
Angina Pectoris Drugs Market Size, Share 2022
Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological stress. Angina pectoris is categorized as - stable, unstable, microvascular and Prinzmetal / variant. Angina pectoris is an initial presentation of coronary heart disease (CHD) and exerts a major impact on quality of life (QOL), costs to the society and ability to work.
This report contains market size and forecasts of Angina Pectoris Drugs in Global, including the following market information:
Global top five companies in 2021 (%)
The global Angina Pectoris Drugs market was valued at 8865.7 million in 2021 and is projected to reach US$ 12640 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Beta Blockers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angina Pectoris Drugs include Pfizer, Bayer, AstraZeneca, Gilead, Novartis, GlaxoSmithKline, Merck, Mylan and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Angina Pectoris Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angina Pectoris Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Angina Pectoris Drugs Market Segment Percentages, by Type, 2021 (%)
- Beta Blockers
- Calcium Antagonists
- Anticoagulants
- Anti-Platelets
- Others
Global Angina Pectoris Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Angina Pectoris Drugs Market Segment Percentages, by Application, 2021 (%)
Global Angina Pectoris Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Angina Pectoris Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Angina Pectoris Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Angina Pectoris Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Bayer
- AstraZeneca
- Gilead
- Novartis
- GlaxoSmithKline
- Merck
- Mylan
- Teva Pharmaceutical
| Report Attributes |
Report Details |
| Report Title |
Angina Pectoris Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Angina Pectoris Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angina Pectoris Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Angina Pectoris Drugs Overall Market Size
2.1 Global Angina Pectoris Drugs Market Size: 2021 VS 2028
2.2 Global Angina Pectoris Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Angina Pectoris Drugs Players in Global Market
3.2 Top Global Angina Pectoris Drugs Companies Ranked by Revenue
3.3 Global Angina Pectoris Drugs Revenue by Companies
3.4 Top 3 and Top 5 Angina Pectoris Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Angina Pectoris Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Angina Pectoris Drugs Players in Global Market
3.6.1 List of Global Tier 1 Angina Pectoris Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Angina Pectoris Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Angina Pectoris Drugs Market Size Markets, 2021 & 2028
4.1.2 Beta Blockers
4.1.3 Calcium Antagonists
4.1.4 Anticoagulants
4.1.5 Anti-Platelets
4.1.6 Others
4.2 By Type - Global Angina Pectoris Drugs Revenue & Forecasts
4.2.1 By Type - Global Angina Pectoris Drugs Revenue, 2017-2022
4.2.2 By Type - Global Angina Pectoris Drugs Revenue, 2023-2028
4.2.3 By Type - Global Angina Pectoris Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Angina Pectoris Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 ASCs
5.2 By Application - Global Angina Pectoris Drugs Revenue & Forecasts
5.2.1 By Application - Global Angina Pectoris Drugs Revenue, 2017-2022
5.2.2 By Application - Global Angina Pectoris Drugs Revenue, 2023-2028
5.2.3 By Application - Global Angina Pectoris Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Angina Pectoris Drugs Market Size, 2021 & 2028
6.2 By Region - Global Angina Pectoris Drugs Revenue & Forecasts
6.2.1 By Region - Global Angina Pectoris Drugs Revenue, 2017-2022
6.2.2 By Region - Global Angina Pectoris Drugs Revenue, 2023-2028
6.2.3 By Region - Global Angina Pectoris Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Angina Pectoris Drugs Revenue, 2017-2028
6.3.2 US Angina Pectoris Drugs Market Size, 2017-2028
6.3.3 Canada Angina Pectoris Drugs Market Size, 2017-2028
6.3.4 Mexico Angina Pectoris Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Angina Pectoris Drugs Revenue, 2017-2028
6.4.2 Germany Angina Pectoris Drugs Market Size, 2017-2028
6.4.3 France Angina Pectoris Drugs Market Size, 2017-2028
6.4.4 U.K. Angina Pectoris Drugs Market Size, 2017-2028
6.4.5 Italy Angina Pectoris Drugs Market Size, 2017-2028
6.4.6 Russia Angina Pectoris Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Angina Pectoris Drugs Market Size, 2017-2028
6.4.8 Benelux Angina Pectoris Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Angina Pectoris Drugs Revenue, 2017-2028
6.5.2 China Angina Pectoris Drugs Market Size, 2017-2028
6.5.3 Japan Angina Pectoris Drugs Market Size, 2017-2028
6.5.4 South Korea Angina Pectoris Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Angina Pectoris Drugs Market Size, 2017-2028
6.5.6 India Angina Pectoris Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Angina Pectoris Drugs Revenue, 2017-2028
6.6.2 Brazil Angina Pectoris Drugs Market Size, 2017-2028
6.6.3 Argentina Angina Pectoris Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Angina Pectoris Drugs Revenue, 2017-2028
6.7.2 Turkey Angina Pectoris Drugs Market Size, 2017-2028
6.7.3 Israel Angina Pectoris Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Angina Pectoris Drugs Market Size, 2017-2028
6.7.5 UAE Angina Pectoris Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Angina Pectoris Drugs Major Product Offerings
7.1.4 Pfizer Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Angina Pectoris Drugs Major Product Offerings
7.2.4 Bayer Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.2.5 Bayer Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Angina Pectoris Drugs Major Product Offerings
7.3.4 AstraZeneca Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Gilead
7.4.1 Gilead Corporate Summary
7.4.2 Gilead Business Overview
7.4.3 Gilead Angina Pectoris Drugs Major Product Offerings
7.4.4 Gilead Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.4.5 Gilead Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Angina Pectoris Drugs Major Product Offerings
7.5.4 Novartis Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Angina Pectoris Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Angina Pectoris Drugs Major Product Offerings
7.7.4 Merck Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.7.5 Merck Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Angina Pectoris Drugs Major Product Offerings
7.8.4 Mylan Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.8.5 Mylan Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Angina Pectoris Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Angina Pectoris Drugs Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Angina Pectoris Drugs Market Opportunities & Trends in Global Market
Table 2. Angina Pectoris Drugs Market Drivers in Global Market
Table 3. Angina Pectoris Drugs Market Restraints in Global Market
Table 4. Key Players of Angina Pectoris Drugs in Global Market
Table 5. Top Angina Pectoris Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Angina Pectoris Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Angina Pectoris Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Angina Pectoris Drugs Product Type
Table 9. List of Global Tier 1 Angina Pectoris Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angina Pectoris Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Angina Pectoris Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Angina Pectoris Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Angina Pectoris Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Angina Pectoris Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Angina Pectoris Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Angina Pectoris Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Angina Pectoris Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Angina Pectoris Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Angina Pectoris Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Angina Pectoris Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Angina Pectoris Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Angina Pectoris Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Angina Pectoris Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Angina Pectoris Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Angina Pectoris Drugs Product Offerings
Table 32. Pfizer Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Angina Pectoris Drugs Product Offerings
Table 35. Bayer Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Angina Pectoris Drugs Product Offerings
Table 38. AstraZeneca Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Gilead Corporate Summary
Table 40. Gilead Angina Pectoris Drugs Product Offerings
Table 41. Gilead Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Angina Pectoris Drugs Product Offerings
Table 44. Novartis Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Angina Pectoris Drugs Product Offerings
Table 47. GlaxoSmithKline Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Angina Pectoris Drugs Product Offerings
Table 50. Merck Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Mylan Corporate Summary
Table 52. Mylan Angina Pectoris Drugs Product Offerings
Table 53. Mylan Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Angina Pectoris Drugs Product Offerings
Table 56. Teva Pharmaceutical Angina Pectoris Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Angina Pectoris Drugs Segment by Type in 2021
Figure 2. Angina Pectoris Drugs Segment by Application in 2021
Figure 3. Global Angina Pectoris Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Angina Pectoris Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Angina Pectoris Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Angina Pectoris Drugs Revenue in 2021
Figure 8. By Type - Global Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 12. US Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 24. China Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Angina Pectoris Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Angina Pectoris Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Gilead Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mylan Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Angina Pectoris Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
